Comparing low-dose vs. direct-inject buprenorphine for fentanyl users
Part of Mental health clinical trials.
This study compares two ways to start buprenorphine (a medicine for opioid use disorder) for people who use fentanyl daily. One group gets a low starting dose, the other gets a direct injection. The goal is to see which approach helps people stay in treatment longer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have been using fentanyl almost every day (at least 5 out of the last 7 days)
- You want to stop or cut down on fentanyl and are willing to try a medication called buprenorphine
- You have San Francisco Medicaid or Medicare to cover the pharmacy costs
- You are not pregnant, nursing, or planning pregnancy in the next 6 months
- You are not currently using methadone or buprenorphine (per a urine test)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two medications, methadone and buprenorphine, to see which helps people stay in treatment for opioid use disorder. You may be eligible if you are starting a new treatment episode.
This study compares a higher dose of buprenorphine (a medicine that helps stop opioid cravings and withdrawal) to the usual dose, given in the emergency department. It aims to see if the higher dose works better to start treatment for opioid use disorder.
This study tests two different forms of buprenorphine (a medication for opioid addiction) to see which works better for people who use fentanyl or other strong synthetic opioids. If you are seeking treatment for opioid use, this trial may help you find the most effective option.
This trial tests a way to quickly start buprenorphine (a medication for opioid addiction) in an outpatient clinic for people who use fentanyl. It aims to make starting treatment easier and faster, without needing to go through full withdrawal first.
This Phase 3 study tests whether starting a high dose of buprenorphine in the emergency department helps people with opioid use disorder come through withdrawal more safely and effectively. It focuses on people whose urine test shows fentanyl and who are already in withdrawal when they arrive.
This trial compares taking buprenorphine by mouth versus as an injection for opioid use disorder. It aims to see which option helps people stay on treatment and reduces opioid use over about a year.
Hear when a new Opioid Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.